https://www.pharmaceutical-technology.com/data-insights/brimarafenib-mapkure-colorectal-cancer-likelihood-of-approval/
Brimarafenib is under clinical development by MapKure and currently in Phase I for Colorectal Cancer.
colorectal cancerbrimarafeniblikelihoodapproval